Omega-3 fatty acids and traumatic neurological injury: From neuroprotection to neuroplasticity?

Trends in Neurosciences

Volumn 37, Issue 1, 2014, Pages 30-38

  Michael Titus, Adina T ^a   Priestley, John V ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; NEUROPROTECTIVE AGENT;

DIET SUPPLEMENTATION; HUMAN; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NERVOUS SYSTEM INJURY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN INJURIES; CONVALESCENCE; DRUG EFFECTS; PHYSIOLOGY; SPINAL CORD INJURIES;

ANIMALS; BRAIN INJURIES; FATTY ACIDS, OMEGA-3; HUMANS; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; RECOVERY OF FUNCTION; SPINAL CORD INJURIES;

EID: 84891359889     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2013.10.005     Document Type: Review

References (118)

1. Risdall J.E., Menon D.K. Traumatic brain injury. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2011, 366:241-250.
2. Weaver F.M., et al. Provider perspectives on soldiers with new spinal cord injuries returning from Iraq and Afghanistan. Arch. Phys. Med. Rehabil. 2009, 90:517-521.
3. Testa J.A., et al. Outcome after traumatic brain injury: effects of aging on recovery. Arch. Phys. Med. Rehabil. 2005, 86:1815-1823.
4. Franceschini M., et al. Age influences rehabilitative outcomes in patients with spinal cord injury (SCI). Aging Clin. Exp. Res. 2011, 23:202-208.
5. Roozenbeek B., et al. Changing patterns in the epidemiology of traumatic brain injury. Nat. Rev. Neurol. 2013, 9:231-236.
6. Wilson J.R., et al. Early versus late surgery for traumatic spinal cord injury: the results of a prospective Canadian cohort study. Spinal Cord 2012, 50:840-843.
7. Fehlings M.G., et al. Early versus delayed decompression for traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS). PLoS ONE 2012, 7:e32037.
8. Hou S., et al. Plasticity of lumbosacral propriospinal neurons is associated with the development of autonomic dysreflexia after thoracic spinal cord transection. J. Comp. Neurol. 2008, 509:382-399.
9. Mann R., et al. Burden of spinal cord injury-related neuropathic pain in the United States: retrospective chart review and cross-sectional survey. Spinal Cord 2013, 51:564-570.
10. Hurlbert R.J., et al. Pharmacological therapy for acute spinal cord injury. Neurosurgery 2013, 72(Suppl. 2):93-105.
11. Loane D.J., Faden A.I. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol. Sci. 2010, 31:596-604.
12. Priestley J.V., et al. Limiting spinal cord injury by pharmacological intervention. Handb. Clin. Neurol. 2012, 109:463-484.
13. Senter H.J., Venes J.L. Loss of autoregulation and posttraumatic ischemia following experimental spinal cord trauma. J. Neurosurg. 1979, 50:198-206.
14. Profyris C., et al. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol. Dis. 2004, 15:415-436.
15. Liu D., et al. Neurotoxicity of glutamate at the concentration released upon spinal cord injury. Neuroscience 1999, 93:1383-1389.
16. Xu G.Y., et al. Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord. Exp. Neurol. 2004, 187:329-336.
17. Pilitsis J.G., et al. Free fatty acids in cerebrospinal fluids from patients with traumatic brain injury. Neurosci. Lett. 2003, 349:136-138.
18. Lopez-Vales R., et al. Fenretinide promotes functional recovery and tissue protection after spinal cord contusion injury in mice. J. Neurosci. 2010, 30:3220-3226.
19. Donnelly D.J., Popovich P.G. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol. 2008, 209:378-388.
20. Lenzlinger P.M., et al. The duality of the inflammatory response to traumatic brain injury. Mol. Neurobiol. 2001, 24:169-181.
21. Beck K.D., et al. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 2010, 133:433-447.
22. Fleming J.C., et al. The cellular inflammatory response in human spinal cords after injury. Brain 2006, 129:3249-3269.
23. Sroga J.M., et al. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J. Comp. Neurol. 2003, 462:223-240.
24. Frugier T., et al. In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J. Neurotrauma 2010, 27:497-507.
25. Hall J.C., et al. Docosahexaenoic acid, but not eicosapentaenoic acid, reduces the early inflammatory response following compression spinal cord injury in the rat. J. Neurochem. 2012, 121:738-750.
26. Frost F., et al. Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury. Arch. Phys. Med. Rehabil. 2005, 86:312-317.
27. Bradbury E.J., et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416:636-640.
28. Faulkner J.R., et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 2004, 24:2143-2155.
29. Myer D.J., et al. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 2006, 129:2761-2772.
30. Xiong Y., et al. Effects of posttraumatic carbamylated erythropoietin therapy on reducing lesion volume and hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome in rats following traumatic brain injury. J. Neurosurg. 2011, 114:549-559.
31. Felix M.S., et al. Alteration of forebrain neurogenesis after cervical spinal cord injury in the adult rat. Front. Neurosci. 2012, 6:45.
32. Freund P., et al. Disability, atrophy and cortical reorganization following spinal cord injury. Brain 2011, 134:1610-1622.
33. Medana I.M., Esiri M.M. Axonal damage: a key predictor of outcome in human CNS diseases. Brain 2003, 126:515-530.
34. Bazarian J.J., et al. Diffusion tensor imaging detects clinically important axonal damage after mild traumatic brain injury: a pilot study. J. Neurotrauma 2007, 24:1447-1459.
35. Choo A.M., et al. Secondary pathology following contusion, dislocation, and distraction spinal cord injuries. Exp. Neurol. 2008, 212:490-506.
36. Totoiu M.O., Keirstead H.S. Spinal cord injury is accompanied by chronic progressive demyelination. J. Comp. Neurol. 2005, 486:373-383.
37. Guest J.D., et al. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp. Neurol. 2005, 192:384-393.
38. Curt A., et al. Recovery from a spinal cord injury: significance of compensation, neural plasticity, and repair. J. Neurotrauma 2008, 25:677-685.
39. Fouad K., Tetzlaff W. Rehabilitative training and plasticity following spinal cord injury. Exp. Neurol. 2012, 235:91-99.
40. Schwab J.M., et al. Injury reactive myelin/oligodendrocyte-derived axon growth inhibition in the adult mammalian central nervous system. Brain Res. Brain Res. Rev. 2005, 49:295-299.
41. Wang X., et al. Recovery from chronic spinal cord contusion after Nogo receptor intervention. Ann. Neurol. 2011, 70:805-821.
42. Hanell A., et al. Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice. J. Neurotrauma 2010, 27:1297-1309.
43. Carulli D., et al. Chondroitin sulfate proteoglycans in neural development and regeneration. Curr. Opin. Neurobiol. 2005, 15:116-120.
44. Kwok J.C., et al. Proteoglycans in the central nervous system: plasticity, regeneration and their stimulation with chondroitinase ABC. Restor. Neurol. Neurosci. 2008, 26:131-145.
45. Harris N.G., et al. Chondroitinase enhances cortical map plasticity and increases functionally active sprouting axons after brain injury. J. Neurotrauma 2013, 30:1257-1269.
46. Gerster H. Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)?. Int. J. Vitam. Nutr. Res. 1998, 68:159-173.
47. Pawlosky R.J., et al. Physiological compartmental analysis of a-linolenic acid metabolism in adult humans. J. Lipid Res. 2001, 42:1257-1265.
48. Burdge G.C., et al. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br. J. Nutr. 2002, 88:355-363.
49. Brenna J.T. Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr. Opin. Clin. Nutr. Metab. Care 2002, 5:127-132.
50. Simopoulos A.P. Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins Leukot. Essent. Fatty Acids 1999, 60:421-429.
51. Ferrucci L., et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J. Clin. Endocrinol. Metab. 2006, 91:439-446.
52. Harris W.S. The omega-3 index: clinical utility for therapeutic intervention. Curr. Cardiol. Rep. 2010, 12:503-508.
53. Pelsers M.M., Glatz J.F. Detection of brain injury by fatty acid-binding proteins. Clin. Chem. Lab. Med. 2005, 43:802-809.
54. King V.R., et al. Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J. Neurosci. 2006, 26:4672-4680.
55. Huang W.L., et al. A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 2007, 130:3004-3019.
56. Ward R.E., et al. Docosahexaenoic acid prevents white matter damage after spinal cord injury. J. Neurotrauma 2010, 27:1769-1780.
57. Lim S.N., et al. The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats. Prostaglandins Leukot. Essent. Fatty Acids 2010, 83:193-201.
58. Lim S.N., et al. Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid. Exp. Neurol. 2013, 239:13-27.
59. Lim S.N., et al. Transgenic mice with high endogenous omega-3 fatty acids are protected from spinal cord injury. Neurobiol. Dis. 2013, 51:104-112.
60. Figueroa J.D., et al. Docosahexaenoic acid pretreatment confers protection and functional improvements after acute spinal cord injury in adult rats. J. Neurotrauma 2012, 29:551-566.
61. Akbar M., et al. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10858-10863.
62. Akbar M., Kim H.Y. Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J. Neurochem. 2002, 82:655-665.
63. Figueroa J.D., et al. Dietary omega-3 polyunsaturated fatty acids improve the neurolipidome and restore the DHA status while promoting functional recovery after experimental spinal cord injury. J. Neurotrauma 2013, 30:853-868.
64. Bailes J.E., Mills J.D. Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model. J. Neurotrauma 2010, 27:1617-1624.
65. Mills J.D., et al. Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model. J. Neurosurg. 2011, 114:77-84.
66. Wu A., et al. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J. Neurotrauma 2004, 21:1457-1467.
67. Wu A., et al. Omega-3 fatty acids supplementation restores mechanisms that maintain brain homeostasis in traumatic brain injury. J. Neurotrauma 2007, 24:1587-1595.
68. Mills J.D., et al. Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury. Neurosurgery 2011, 68:474-481. discussion 481.
69. Wu A., et al. Exercise facilitates the action of dietary DHA on functional recovery after brain trauma. Neuroscience 2013, 48:655-663.
70. Shin S.S., Dixon C.E. Oral fish oil restores striatal dopamine release after traumatic brain injury. Neurosci. Lett. 2011, 496:168-171.
71. Dyall S.C., Michael-Titus A.T. Neurological benefits of omega-3 fatty acids. Neuromol. Med. 2008, 10:219-235.
72. Vreugdenhil M., et al. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:12559-12563.
73. Heurteaux C., et al. TREK-1, a K+ channel involved in neuroprotection and general anesthesia. EMBO J. 2004, 23:2684-2695.
74. Namiranian K., et al. Traumatic brain injury in mice lacking the K channel, TREK-1. J. Cereb. Blood Flow Metab. 2011, 31:e1-e6.
75. de Urquiza A.M., et al. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 2000, 290:2140-2144.
76. Schrage K., et al. Macrophages and neurons are targets of retinoic acid signaling after spinal cord contusion injury. Eur. J. Neurosci. 2006, 23:285-295.
77. Takenaga M., et al. The effect of Am-80, a synthetic retinoid, on spinal cord injury-induced motor dysfunction in rats. Biol. Pharm. Bull. 2009, 32:225-231.
78. Dheen S.T., et al. Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. Glia 2005, 50:21-31.
79. McTigue D.M., et al. The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury. Exp. Neurol. 2007, 205:396-406.
80. Yi J.H., et al. PPARγ agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Brain Res. 2008, 1244:164-172.
81. Oh D.Y., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.
82. Katsuma S., et al. Free fatty acids inhibit serum deprivation-induced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1. J. Biol. Chem. 2005, 280:19507-19515.
83. Ma D., et al. Expression of free fatty acid receptor GPR40 in the neurogenic niche of adult monkey hippocampus. Hippocampus 2008, 18:326-333.
84. Honore J.C., et al. Fatty acid receptor Gpr40 mediates neuromicrovascular degeneration induced by transarachidonic acids in rodents. Arterioscler. Thromb. Vasc. Biol. 2013, 33:954-961.
85. Serhan C.N., et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004, 39:1125-1132.
86. Kohli P., Levy B.D. Resolvins and protectins: mediating solutions to inflammation. Br. J. Pharmacol. 2009, 158:960-971.
87. Schwab J.M., et al. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007, 447:869-874.
88. Serhan C.N., et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 2009, 206:15-23.
89. Krishnamoorthy S., et al. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. Am. J. Pathol. 2012, 180:2018-2027.
90. Serhan C.N., et al. Novel anti-inflammatory-pro-resolving mediators and their receptors. Curr. Top. Med. Chem. 2011, 11:629-647.
91. Mukherjee P.K., et al. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8491-8496.
92. Bazan N.G. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol. 2005, 15:159-166.
93. Scheltens P., et al. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J. Alzheimers Dis. 2012, 31:225-236.
94. Calderon F., Kim H.Y. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J. Neurochem. 2004, 90:979-988.
95. Cao D., et al. Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures. J. Nutr. Biochem. 2005, 16:538-546.
96. Robson L.G., et al. Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals. Neurobiol. Aging 2010, 31:678-687.
97. Wu A., et al. The salutary effects of DHA dietary supplementation on cognition, neuroplasticity, and membrane homeostasis after brain trauma. J. Neurotrauma 2011, 28:2113-2122.
98. Yang H., et al. Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury. J. Neurosci. 2006, 26:2157-2166.
99. Kernie S.G., Parent J.M. Forebrain neurogenesis after focal ischaemic and traumatic brain injury. Neurobiol. Dis. 2010, 37:267-274.
100. Xiong Y., et al. Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice. J. Neurosurg. 2008, 109:510-521.
101. He C., et al. Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:11370-11375.
102. Hu X., et al. Transgenic overproduction of omega-3 polyunsaturated fatty acids provides neuroproection and enhances endogenous neurogenesis after stroke. Curr. Mol. Med. 2013, 13:1465-1473.
103. O'Connor W.T., et al. Animal models of traumatic brain injury: a critical evaluation. Pharmacol. Ther. 2011, 130:106-113.
104. Marklund N., Hillered L. Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?. Br. J. Pharmacol. 2011, 164:1207-1229.
105. Morales D., et al. Experimental models of traumatic brain injury: do we really need to build a better mousetrap?. Neuroscience 2005, 136:971-989.
106. Marques S.A., et al. A simple, inexpensive and easily reproducible model of spinal cord injury in mice: morphological and functional assessment. J. Neurosci. Methods 2009, 177:183-193.
107. Rosenzweig E.S., McDonald J.W. Rodent models for treatment of spinal cord injury: research trends and progress toward useful repair. Curr. Opin. Neurol. 2004, 17:121-131.
108. Basso D.M., et al. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 1996, 139:244-256.
109. Basso D.M., et al. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 2006, 23:635-659.
110. Hamers F.P., et al. Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J. Neurotrauma 2001, 18:187-201.
111. Schmitz G., Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog. Lipid Res. 2008, 47:147-155.
112. Huang T.L., et al. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 2005, 65:1409-1414.
113. Zhou W., et al. Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J. Neurotrauma 2008, 25:279-290.
114. Lo E.H. A new penumbra: transitioning from injury into repair after stroke. Nat. Med. 2008, 14:497-500.
115. Calder P.C., Deckelbaum R.J. Intravenous fish oil in hospitalized adult patients: reviewing the reviews. Curr. Opin. Clin. Nutr. Metab. Care 2013, 16:119-123.
116. Blesch A., Tuszynski M.H. Spinal cord injury: plasticity, regeneration and the challenge of translational drug development. Trends Neurosci. 2009, 32:41-47.
117. Saatman K.E., et al. Classification of traumatic brain injury for targeted therapies. J. Neurotrauma 2008, 25:719-738.
118. Gladman S.J., et al. Improved outcome after peripheral nerve injury in mice with increased levels of endogenous omega-3 polyunsaturated fatty acids. J. Neurosci. 2012, 32:563-571.